Bone Pharm Flashcards

(46 cards)

1
Q

Hormones

A

Teriparatide

calcitonin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Vit D

A

choecalciferol (D3)
ergocalciferol (D2)
Calcitriol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Estrogen R modulators

A

Raloxifene

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Bisphosphonates

A

Alendronate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MABs

A

denosumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

appendicular bone

A

80% of bone mass

mostly compact cortical bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

axial bone

A

trabecular

alteration in bone turn-over occur here

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

OPG

A

decoy R for RANKL
produced by osteoblasts
suppressed by estrogen deprivation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

normal Ca

A

8.5-10.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

normal Phosphate

A

2.5-4.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PTH and bone

A
increases activity and number of osteoclasts by binding osteoblasts which release RANKL which activates osteoclasts
inhibits sclerostin (inhibits osteoblasts) from osteocytes, but net effect is still bone break down
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

PTH and kiindey

A

increase Ca resorption
increases Phosphorous excretion
sitimulates vit D activation
increases Mg resorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

teleparatide

A

synthetic recombinant human parathyroid hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

teleparatide MOA

A

continuous administration causes bone demineralization

intermittent promotes growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

uses of teleparatide

A

women w/Hx of osteoporotic fracture and failed other drug therapy
men with primary hypogonadal osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ADRs teleparatide

A
orthostatic hypotension
hypercalemia
dizziness, nausea
hyperuricemia
anggina
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

teleparatide CI

A

pts with increased risk of osteosarcoma: pagets, elevated alk phos, open epiphyses, prior radiation therapy of skeleton

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Calcitriol actions

A

augments intestinal absorption and retention of Ca and phos
increases bone turnover by
-recruitment and activation of osteoclasts
-increasing RANKL and osteocalcin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

otherwise healthy what type of vit D do you Tx with?

A

ergocalciferol or cholecalciferol

20
Q

liver dis what type of D do you Tx with?

21
Q

kindey dis what type of D do you Tx with?

22
Q

what can vit D be used to Tx

A

rickets
hypoparathyroidism
prevention and Tx of osteoporosis

23
Q

ADRs to vit D

A

hypercalcemia -> n/v constipation
hyperphosphatemia
arrhythmias and pancreatitis

24
Q

FGF23

A

inhibits 1,25 (OH)2D production and phosphate resorption in kidney
produced by osteocytes and osteoblasts

25
calcitonin
decreases serum Ca and phos inhibits osteoclasts decreases Ca and Phos resorption in kidney
26
uses of calcitonin
pagets osteoporosis hypercalcemia
27
ADRs of calcitonin
nausea, hand swelling, urticaria, intestinal cramping
28
estrogens
prevent bone loss post-menopause | SERM (raloxifene) less ADRs then E
29
raloxifene ADRs
hot flashes leg cramps thromboemoblism (3x increased risk)
30
CI of raloxifene
Hx of venous thromboembolism CAD strokes
31
bisphosphonate mOA
analogs of pyrophosphonate with C chelate Ca incorporate into bone decrease formation and dissolution of hydroxyapatite crystals and inhibit osteoclasts
32
PK of bisphosphonates
must be taken on empty stomach 30 min before meal | must be sitting upright and taken with full glass of water
33
uses of bisphos
osteoporosis hypercalcemia of malignancy pagets
34
ADRs of bisphos
osteonecrosis of the jaw | subtrochanteric femur fractures
35
Denosumab MOA
binds RANKL | mimics osteoprotegrin
36
PK of denosumab
sub-q every 6 months
37
denosumab ADRs
possible immunosuppression risk of osteonecoris of jaw and subtrochanteric fractures (maybe) transietn hypocalcemia
38
cincalcet MOA
activated CaSR -> inhibits PTH secretion
39
uses of cincalcet
secondary hyperparathyroidism
40
hypercalcemia Tx
``` saline diuresis +/- furosemide bisphos calcitonin (takes 4-6hrs) IV phosphate (fastest, but must be very careful) glucocorticoids ```
41
hypocalcemia Tx
Ca (IV, IM, or PO) If IV Ca gluconate preferred Vit D
42
hyperphosphotemia Tx
- restrict dietary phosphate - phosphate binding gels (Ca) - aboid aluminum antacids
43
primary hyperparathyroidism
surgery
44
secondary hyperparathyroidism
vit D | cinacalcet
45
hypoparathyroidism
Ca | Vit D
46
pagets
calcitonin and bisphosphonates (only for 6 months at a time)